News originally published by S&P Global Multiple partners have created a taskforce to tackle African animal trypanosomiasis. S&P Global’s head of animal health Joseph Harvey spoke to GALVmed’s AAT development program manager Michael Pearce to garner more details about this new alliance. A new collaboration has brought together partners from industry, academia and government to […]

GALVmed is pleased to announce the appointment of Dr Karelle de Luca as Head of Research & Development, effective August 27th, 2023. Dr de Luca is a researcher with deep knowledge, expertise and connections in the fields of immunology & vaccinology. Curious and determined to make a tangible difference through her work, she comes to […]

Edinburgh, UK.   African animal trypanosomiasis (AAT), also known as nagana, is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year. The Bill and Melinda Gates Foundation, the UK Government Foreign Commonwealth and Development Office, Boehringer Ingelheim and GALVmed have joined forces to find a new […]